Sage Journals: Discover world-class research

Open access

Case report

First published 2024

First line treatment with subcutaneous efgartigimod in impending myasthenic crisis: a case report

Isabelle Kwiedor, Martina Menacher, Monika Ellßel [...]

Therapeutic Advances in Neurological Disorders

Retricted access

Research article

First published 2023-10

Neonatal Fc Receptor Inhibition Enables Adeno-Associated Virus Gene Therapy Despite Pre-Existing Humoral Immunity

Makoto Horiuchi, Christian J. Hinderer, Hailey N. Shankle [...]

Human Gene Therapy

Open access

Research article

First published 2026-3

Euthyroidism and Long-Term Remission of Graves’ Hyperthyroidism Following Treatment With an FcRn Blocker: A Case Report

George J. Kahaly, Jan Wolf, Maximilian Luffy [...]

Thyroid®

Open access

Review article

First published 2021

The importance of FcRn in neuro-immunotherapies: From IgG catabolism,FCGRT gene polymorphisms,IVIg dosing and efficiency to specific FcRn inhibitors

Marinos C. Dalakas, Peter J. Spaeth

Therapeutic Advances in Neurological Disorders

Open access

Review article

First published 2023

Efgartigimod alfa for the treatment of primary immune thrombocytopenia

Catherine Broome

Therapeutic Advances in Hematology

Open access

Review article

First published 2021

Updates on the understanding and management of thyroid eye disease

Clara J. Men, Andrea L. Kossler, Sara T. Wester

Therapeutic Advances in Ophthalmology

Open access

Review article

First published 2021

Advances and challenges in the treatment of myasthenia gravis

Christiane Schneider-Gold, Nils Erik Gilhus

Therapeutic Advances in Neurological Disorders

Open access

Case report

First published 2026

Emergency use of eculizumab in impending and manifest myasthenic crisis: a retrospective case series

Ying Huang, Yihan Xiong, Hui Zhan [...]

Therapeutic Advances in Neurological Disorders

Search results